BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

734 related articles for article (PubMed ID: 15451795)

  • 1. Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease.
    Hlatky MA; Boothroyd DB; Melsop KA; Brooks MM; Mark DB; Pitt B; Reeder GS; Rogers WJ; Ryan TJ; Whitlow PL; Wiens RD
    Circulation; 2004 Oct; 110(14):1960-6. PubMed ID: 15451795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators.
    Hlatky MA; Rogers WJ; Johnstone I; Boothroyd D; Brooks MM; Pitt B; Reeder G; Ryan T; Smith H; Whitlow P; Wiens R; Mark DB
    N Engl J Med; 1997 Jan; 336(2):92-9. PubMed ID: 8988886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and economic outcomes of multivessel coronary stenting compared with bypass surgery: a single-center US experience.
    Reynolds MR; Neil N; Ho KK; Berezin R; Cosgrove RS; Lager RA; Sirois C; Johnson RG; Cohen DJ
    Am Heart J; 2003 Feb; 145(2):334-42. PubMed ID: 12595853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple vessel revascularization: coronary angioplasty versus coronary artery bypass surgery: initial results and five-year follow-up. Comparative costs and loss of working days and wages.
    Myler RK; Shaw RE; Stertzer SH; Zapolanski A; Zipkin R; Murphy MC; Hecht H; Chan J; Mengarelli L; Cumberland DC
    J Invasive Cardiol; 1994 May; 6(4):125-35. PubMed ID: 10147165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative cost comparison of treatments for coronary artery disease: the First Year Follow-Up of MASS II Study.
    Favarato D; Hueb W; Gersh BJ; Soares PR; Cesar LA; da Luz PL; Oliveira SA; Ramires JA;
    Circulation; 2003 Sep; 108 Suppl 1():II21-3. PubMed ID: 12970202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty. Twenty-year clinical outcome.
    van Domburg RT; Foley DP; Breeman A; van Herwerden LA; Serruys PW
    Eur Heart J; 2002 Apr; 23(7):543-9. PubMed ID: 11922644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
    Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of high-risk patients.
    Stroupe KT; Morrison DA; Hlatky MA; Barnett PG; Cao L; Lyttle C; Hynes DM; Henderson WG;
    Circulation; 2006 Sep; 114(12):1251-7. PubMed ID: 16966588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of age on outcomes after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: one-year results from the Stent or Surgery (SoS) trial.
    Zhang Z; Mahoney EM; Spertus JA; Booth J; Nugara F; Kolm P; Stables RH; Weintraub WS
    Am Heart J; 2006 Dec; 152(6):1153-60. PubMed ID: 17161069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution.
    Li Y; Zheng Z; Xu B; Zhang S; Li W; Gao R; Hu S
    Circulation; 2009 Apr; 119(15):2040-50. PubMed ID: 19349321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
    Bakhai A; Stone GW; Mahoney E; Lavelle TA; Shi C; Berezin RH; Lahue BJ; Clark MA; Lacey MJ; Russell ME; Ellis SG; Hermiller JB; Cox DA; Cohen DJ;
    J Am Coll Cardiol; 2006 Jul; 48(2):253-61. PubMed ID: 16843171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST).
    King SB; Lembo NJ; Weintraub WS; Kosinski AS; Barnhart HX; Kutner MH; Alazraki NP; Guyton RA; Zhao XQ
    N Engl J Med; 1994 Oct; 331(16):1044-50. PubMed ID: 8090163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Balloon angioplasty versus bypass grafting in the era of coronary stenting.
    Ekstein S; Elami A; Merin G; Gotsman MS; Lotan C
    Isr Med Assoc J; 2002 Aug; 4(8):583-9. PubMed ID: 12183860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of minimally invasive coronary bypass and percutaneous transluminal coronary angioplasty in the treatment of double-vessel coronary disease: Two-year follow-up of a new hybrid procedure compared with "on-pump" double bypass grafting.
    de Cannière D; Jansens JL; Goldschmidt-Clermont P; Barvais L; Decroly P; Stoupel E
    Am Heart J; 2001 Oct; 142(4):563-70. PubMed ID: 11579343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Economic evaluation of different treatment strategies in patients with stable angina pectoris or asymptomatic myocardial ischemia on basis of results from the Asymptomatic-Cardiac-Ischemia Pilot study (ACIP)].
    Szucs TD; Schwenkglenks M; Rutishauser W
    Med Klin (Munich); 2000 Jan; 95(1):1-13. PubMed ID: 10668338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative benefit of coronary artery bypass grafting versus stent-assisted percutaneous coronary intervention for angina pectoris and multivessel coronary disease in women versus men (one-year results from the Stent or Surgery trial).
    Zhang Z; Weintraub WS; Mahoney EM; Spertus JA; Booth J; Nugara F; Stables RH; Vaccarino V
    Am J Cardiol; 2004 Feb; 93(4):404-9. PubMed ID: 14969611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Percutaneous transluminal coronary angioplasty in 1980-85 and 1995-96: more frequent multivessel disease, fewer reoperations and no change in mortality 1 and 5 years postoperatively].
    van Domburg RT; Vos J; Serruys PW
    Ned Tijdschr Geneeskd; 2002 Nov; 146(46):2196-200. PubMed ID: 12467164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The design, patient population and outcomes from the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial and registries.
    Brooks MM; Detre KM
    Semin Interv Cardiol; 1999 Dec; 4(4):191-9. PubMed ID: 10738352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late outcome of multivessel coronary artery disease after angioplasty or bypass surgery.
    Baciewicz PA; Shaw RE; Rosenblum J; Myler RK; Zapolanski A; Anwar A; Stertzer SH; Murphy MC; Hansell HN; Chan J
    J Invasive Cardiol; 1993 Jun; 5(5):179-87. PubMed ID: 10146581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing long-term survival of patients with multivessel coronary disease after CABG or PCI: analysis of BARI-like patients in northern New England.
    Malenka DJ; Leavitt BJ; Hearne MJ; Robb JF; Baribeau YR; Ryan TJ; Helm RE; Kellett MA; Dauerman HL; Dacey LJ; Silver MT; VerLee PN; Weldner PW; Hettleman BD; Olmstead EM; Piper WD; O'Connor GT;
    Circulation; 2005 Aug; 112(9 Suppl):I371-6. PubMed ID: 16159849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.